{"id":"lipid-lowering-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Muscle pain or myalgia"},{"rate":null,"effect":"Elevated liver enzymes"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipid-lowering therapies encompass multiple drug classes (statins, PCSK9 inhibitors, ezetimibe, bempedoic acid, etc.) that work through different mechanisms such as inhibiting HMG-CoA reductase, blocking PCSK9-mediated LDL receptor degradation, or reducing intestinal cholesterol absorption. These agents collectively reduce circulating LDL cholesterol, triglycerides, and other atherogenic lipids to lower cardiovascular risk.","oneSentence":"Lipid-lowering therapy reduces blood cholesterol and triglyceride levels through various pharmacological mechanisms to prevent cardiovascular disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:19:11.133Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hyperlipidemia / dyslipidemia"},{"name":"Cardiovascular disease prevention"},{"name":"Secondary prevention post-myocardial infarction or stroke"}]},"trialDetails":[{"nctId":"NCT03844061","phase":"PHASE2","title":"Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-29","conditions":"Systemic Sclerosis","enrollment":30},{"nctId":"NCT06540456","phase":"","title":"Qutenza 8% Capsaicin Topical System for the Treatment of Neuropathic Axial Lower Back Pain and Lumbosacral Radiculopathy","status":"ENROLLING_BY_INVITATION","sponsor":"Medical University of South Carolina","startDate":"2025-03-13","conditions":"Lower Back Pain, Lumbosacral Radiculopathy","enrollment":50},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT04042935","phase":"PHASE1","title":"Alpha Lipoic Acid to Decrease Pain and Side Effects in Concurrent Treatment of HNSCC","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-02-27","conditions":"HNSCC","enrollment":5},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT05726838","phase":"","title":"The Belgian REAL (BE.REAL) Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-04-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":600},{"nctId":"NCT07464574","phase":"","title":"Optimizing Non-statin Agents for ASCVD","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2026-01-16","conditions":"ASCVD Management","enrollment":1000},{"nctId":"NCT07219602","phase":"PHASE3","title":"A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome","status":"RECRUITING","sponsor":"NewAmsterdam Pharma","startDate":"2025-12-11","conditions":"Lipidemia, Type 2 Diabetes (T2DM), Metabolic Syndrome (MetS)","enrollment":300},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07450378","phase":"PHASE3","title":"QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2026-05","conditions":"Heterozygous Familial Hypercholesterolemia (HeFH)","enrollment":120},{"nctId":"NCT07441317","phase":"PHASE3","title":"QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2026-03","conditions":"Primary Hypercholesterolemia or Mixed Hyperlipidemia","enrollment":780},{"nctId":"NCT07447648","phase":"","title":"Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)","startDate":"2026-03","conditions":"Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography","enrollment":52},{"nctId":"NCT07440381","phase":"PHASE3","title":"triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE","status":"NOT_YET_RECRUITING","sponsor":"Heart Care Foundation","startDate":"2026-09","conditions":"Acute Coronary Syndromes, Secondary Prevention, Lipids","enrollment":600},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT07412457","phase":"","title":"Guideline Adherence in Dyslipidemia With Clinical Decision Support","status":"NOT_YET_RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2026-04-01","conditions":"Dyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries","enrollment":500},{"nctId":"NCT06832371","phase":"","title":"Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)","startDate":"2024-09-09","conditions":"Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia","enrollment":73},{"nctId":"NCT05844566","phase":"NA","title":"OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2023-04-03","conditions":"Acute Coronary Syndrome, Myocardial Infarction","enrollment":1139},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT07421284","phase":"PHASE3","title":"A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy","status":"NOT_YET_RECRUITING","sponsor":"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.","startDate":"2026-03-31","conditions":"Non-familial Hypercholesterolemia and Mixed Hyperlipidemia","enrollment":900},{"nctId":"NCT07415109","phase":"NA","title":"Improving LDL-C Levels Through Temporal Self-regulation Theory-based, Personality-tailored Health Messages: A Three-Arm Randomized Controlled Trial","status":"RECRUITING","sponsor":"National University Health System, Singapore","startDate":"2025-11-25","conditions":"Adherence, Preventive Health Services","enrollment":3000},{"nctId":"NCT05743387","phase":"NA","title":"Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-05-13","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":252},{"nctId":"NCT05684055","phase":"NA","title":"\"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-09-09","conditions":"Arterial Hypertension","enrollment":1354},{"nctId":"NCT07176923","phase":"EARLY_PHASE1","title":"CS-121 APOC3 Base Editing in FCS","status":"RECRUITING","sponsor":"CorrectSequence Therapeutics Co., Ltd","startDate":"2025-10-15","conditions":"Familial Chylomicronemia Syndrome (FCS)","enrollment":15},{"nctId":"NCT07399743","phase":"PHASE3","title":"Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2026-02-15","conditions":"Knee Osteoarthritis","enrollment":160},{"nctId":"NCT06960655","phase":"NA","title":"Improving Lipid Optimization Quality and Treatment Options in ASCVD","status":"ENROLLING_BY_INVITATION","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-14","conditions":"Hypercholesterolemia, ASCVD","enrollment":300},{"nctId":"NCT06863545","phase":"NA","title":"Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-22","conditions":"Coronary Artery Disease, CT Angiography, PCSK9","enrollment":3596},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT07388420","phase":"NA","title":"Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-02","conditions":"Hypertriglyceridemia Induced Acute Pancreatitis","enrollment":40},{"nctId":"NCT06936111","phase":"","title":"REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-07-01","conditions":"Coronary Heart Disease (CHD)","enrollment":900},{"nctId":"NCT05399992","phase":"","title":"Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-09-12","conditions":"Primary Hypercholesterolemia, Mixed Dyslipidemia","enrollment":847},{"nctId":"NCT06109831","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic","status":"COMPLETED","sponsor":"Beijing Suncadia Pharmaceuticals Co., Ltd","startDate":"2023-11-24","conditions":"Hyperlipidemic","enrollment":335},{"nctId":"NCT04871412","phase":"PHASE3","title":"The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-04-04","conditions":"Lung Cancer, Gastric Cancer, Esophageal Cancer","enrollment":20},{"nctId":"NCT04894877","phase":"","title":"ISCHEMIA-EXTEND (Extended Follow-up)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-07","conditions":"Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease","enrollment":5391},{"nctId":"NCT07229118","phase":"PHASE1","title":"A Study to Evaluate COR-1004 in Adult Volunteers.","status":"RECRUITING","sponsor":"Corsera Health","startDate":"2025-11-28","conditions":"Hyperlipidemia","enrollment":60},{"nctId":"NCT07208006","phase":"NA","title":"Very Early PCSK9 Inhibition for Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-01-01","conditions":"Acute Myocardial Infarction (AMI)","enrollment":1518},{"nctId":"NCT05782777","phase":"NA","title":"Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-04-07","conditions":"Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation","enrollment":4310},{"nctId":"NCT06941792","phase":"PHASE4","title":"Inclisiran Effectiveness in China: a Pragmatic Randomized Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-06-17","conditions":"Coronary Heart Disease","enrollment":1590},{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT05088759","phase":"NA","title":"Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-10-08","conditions":"Hyperlipemia, Mixed, ASCVD","enrollment":400},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT07352566","phase":"PHASE4","title":"Utilization of a Microdevice for Psoriasis and Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-01-01","conditions":"Psoriasis, Atopic Dermatitis","enrollment":10},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT07349342","phase":"NA","title":"Stable Versus Unstable Resistance Training Effects on Physical Fitness and Physiological Biomarkers of Untrained Male University Students","status":"ACTIVE_NOT_RECRUITING","sponsor":"Addis Ababa University","startDate":"2025-11-12","conditions":"No Condition, Health Young Males","enrollment":54},{"nctId":"NCT07341958","phase":"NA","title":"INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-02-01","conditions":"Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)","enrollment":242},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT05888103","phase":"PHASE3","title":"Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-07-11","conditions":"Primary Hypercholesterolemia or Mixed Dyslipidemia","enrollment":207},{"nctId":"NCT06866119","phase":"","title":"Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-01","conditions":"Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications","enrollment":45},{"nctId":"NCT03999853","phase":"PHASE1, PHASE2","title":"Butyrate Adjuvant Therapy for Type 1 Diabetes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-07-28","conditions":"Type1diabetes","enrollment":6},{"nctId":"NCT05462262","phase":"NA","title":"Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2022-10-10","conditions":"Coronary Artery Disease Progression","enrollment":2900},{"nctId":"NCT07311941","phase":"","title":"Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-12-30","conditions":"Hyperlipidemia, Cardio Vascular Disease","enrollment":1000},{"nctId":"NCT07310719","phase":"NA","title":"A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital","status":"RECRUITING","sponsor":"Lagos State Health Service Commission","startDate":"2025-10-15","conditions":"Primary Open Angle Glaucoma or Ocular Hypertension","enrollment":138},{"nctId":"NCT06994975","phase":"PHASE3","title":"CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-03","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT04765657","phase":"PHASE3","title":"Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-03-01","conditions":"Hypercholesterolemia","enrollment":345},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT05641753","phase":"PHASE4","title":"Cholesterol Lowering and Residual Risk in Diabetes, Type 1","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-06","conditions":"Type 1 Diabetes","enrollment":125},{"nctId":"NCT05115630","phase":"PHASE2","title":"Off-the-shelf NK Cells + SCT for Myeloid Malignancies","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-04-08","conditions":"Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":24},{"nctId":"NCT07290699","phase":"PHASE4","title":"Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-01-01","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)","enrollment":2442},{"nctId":"NCT06896708","phase":"NA","title":"Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome","status":"RECRUITING","sponsor":"Liu yong","startDate":"2025-08-12","conditions":"Chronic Coronary Syndrome","enrollment":766},{"nctId":"NCT07286474","phase":"NA","title":"Effects of Laser Therapy and Vitamin D Pills on Braces Tooth Movement: A Random Controlled Study","status":"RECRUITING","sponsor":"Universiti Sains Malaysia","startDate":"2025-01-01","conditions":"Malocclusion of Anterior Teeth","enrollment":50},{"nctId":"NCT05362903","phase":"","title":"A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-01-28","conditions":"Hypercholesterolemia","enrollment":1871},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT06855537","phase":"PHASE4","title":"Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-03","conditions":"Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Thin-cap fIbroatheroma","enrollment":2190},{"nctId":"NCT07255820","phase":"PHASE4","title":"Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol","status":"NOT_YET_RECRUITING","sponsor":"Bahria University","startDate":"2026-01-01","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol","enrollment":126},{"nctId":"NCT07256171","phase":"","title":"COAST Study - Cholesterol Optimization After Stroke","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-01-01","conditions":"Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage","enrollment":500},{"nctId":"NCT06791031","phase":"NA","title":"PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2026-01","conditions":"Coronary Artery Disease","enrollment":212},{"nctId":"NCT07252388","phase":"NA","title":"EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention","status":"NOT_YET_RECRUITING","sponsor":"Heart Care Foundation","startDate":"2025-12-11","conditions":"Acute Coronary Syndromes, Chronic Coronary Syndromes","enrollment":240},{"nctId":"NCT06410352","phase":"PHASE4","title":"Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome","status":"RECRUITING","sponsor":"University Medical Center, Kazakhstan","startDate":"2024-03-01","conditions":"Metabolic Syndrome","enrollment":220},{"nctId":"NCT07242599","phase":"PHASE3","title":"Ongericimab Injection Reducing Recurrence of Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12","conditions":"Ischemic Cerebral Infarction","enrollment":4398},{"nctId":"NCT05858879","phase":"NA","title":"Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2024-10-22","conditions":"ASCVD, Coronary Artery Calcification","enrollment":233},{"nctId":"NCT03872401","phase":"PHASE3","title":"Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke","status":"COMPLETED","sponsor":"Amgen","startDate":"2019-06-11","conditions":"Coronary Heart Disease (CHD)","enrollment":12301},{"nctId":"NCT06249165","phase":"PHASE4","title":"VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-12-16","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":130},{"nctId":"NCT05763875","phase":"PHASE3","title":"Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-03-15","conditions":"Hypercholesterolemia","enrollment":350},{"nctId":"NCT04873934","phase":"PHASE3","title":"Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-06-24","conditions":"Acute Coronary Syndrome","enrollment":400},{"nctId":"NCT05783804","phase":"","title":"Plaque Reversal With Early, Aggressive Lipid Lowering Therapy","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-07-07","conditions":"Coronary Artery Disease Progression","enrollment":60},{"nctId":"NCT06423365","phase":"NA","title":"A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2024-10-24","conditions":"Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Cardiovascular Diseases","enrollment":816},{"nctId":"NCT05720156","phase":"","title":"Immunomodulatory Effects of PCSK9 Inhibition","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2024-04-04","conditions":"Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Atherosclerosis","enrollment":""},{"nctId":"NCT07166393","phase":"PHASE2, PHASE3","title":"Valproic AcId for Traumatic BRAin INjury Trial","status":"NOT_YET_RECRUITING","sponsor":"Northwestern University","startDate":"2026-05","conditions":"Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury","enrollment":432},{"nctId":"NCT06300450","phase":"NA","title":"Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-03-01","conditions":"Peripheral Artery Disease, Peripheral Vascular Diseases, Dyslipidemias","enrollment":400},{"nctId":"NCT07174375","phase":"PHASE2, PHASE3","title":"PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-09-15","conditions":"Acute Ischemic Stroke","enrollment":478},{"nctId":"NCT06993597","phase":"","title":"Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2025-09-01","conditions":"Glaucoma","enrollment":60},{"nctId":"NCT04681170","phase":"PHASE3","title":"Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)","status":"COMPLETED","sponsor":"Amryt Pharma","startDate":"2020-12-14","conditions":"Homozygous Familial Hypercholesterolaemia (HoFH)","enrollment":46},{"nctId":"NCT02390284","phase":"PHASE3","title":"Stop Retinal Ganglion Cell Dysfunction Study","status":"TERMINATED","sponsor":"University of Miami","startDate":"2015-09","conditions":"Glaucoma","enrollment":28},{"nctId":"NCT07142408","phase":"PHASE3","title":"The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal","status":"RECRUITING","sponsor":"The Cooper Health System","startDate":"2023-03-13","conditions":"Surgical Wound Infection","enrollment":848},{"nctId":"NCT06898125","phase":"NA","title":"Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients With Lipedema","status":"COMPLETED","sponsor":"Giresun University","startDate":"2023-09-01","conditions":"Lipedema, Pain","enrollment":33},{"nctId":"NCT07139639","phase":"EARLY_PHASE1","title":"Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease","status":"NOT_YET_RECRUITING","sponsor":"Zheng Liu","startDate":"2025-11-01","conditions":"Diabetic Lower Extremity Arterial Disease","enrollment":350},{"nctId":"NCT05753436","phase":"PHASE2","title":"Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Diabetes Mellitus, Type 2, Dyslipidemias, Hypertension","enrollment":72},{"nctId":"NCT06155331","phase":"PHASE2","title":"Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-12-01","conditions":"Breast Cancer Stage 2 and 3","enrollment":44},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT05325034","phase":"NA","title":"Guideline Oriented Approach To Lipid Lowering In Asia-Pacific","status":"RECRUITING","sponsor":"Stephen Nicholls","startDate":"2022-09-15","conditions":"Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis","enrollment":2000},{"nctId":"NCT07123844","phase":"NA","title":"Pumpkin Seeds or Oil Lower Serum Triglyceride Levels in Individuals With Hyperlipidaemia","status":"COMPLETED","sponsor":"Kastamonu University","startDate":"2022-06-01","conditions":"Hyperlipidemia, Overweight","enrollment":159},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT07064135","phase":"NA","title":"Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery","status":"NOT_YET_RECRUITING","sponsor":"Barmherzige Brüder Linz","startDate":"2025-08-04","conditions":"Dyslipidaemias, Carotid Artery Stenoses","enrollment":50},{"nctId":"NCT06722521","phase":"PHASE4","title":"GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-09","conditions":"Primary Prevention, Vascular Calcification","enrollment":7435},{"nctId":"NCT07102511","phase":"PHASE3","title":"Randomized, Placebo-Controlled, Double-Blind, Phase 3b Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH","status":"NOT_YET_RECRUITING","sponsor":"LIB Therapeutics LLC","startDate":"2025-09-01","conditions":"Familial Hypercholesterolemia - Heterozygous","enrollment":150},{"nctId":"NCT06439654","phase":"NA","title":"Atlantic Lipid Lowering Treatment Optimization Program","status":"RECRUITING","sponsor":"Atlantic Health System","startDate":"2024-07-01","conditions":"Familial Hypercholesterolemia, Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia, Apolipoprotein B 100, Familial Defective","enrollment":250},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT06471036","phase":"NA","title":"Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?","status":"RECRUITING","sponsor":"Duke University","startDate":"2024-10-08","conditions":"ASCVD, LDL-C","enrollment":400}],"_emaApprovals":[],"_faersSignals":[{"count":98,"reaction":"WEIGHT INCREASED"},{"count":62,"reaction":"EXTRAPYRAMIDAL DISORDER"},{"count":11,"reaction":"COGNITIVE DISORDER"},{"count":6,"reaction":"AKATHISIA"},{"count":2,"reaction":"DIABETES MELLITUS"},{"count":2,"reaction":"TARDIVE DYSKINESIA"},{"count":1,"reaction":"ACUTE CORONARY SYNDROME"},{"count":1,"reaction":"ASPIRATION BRONCHIAL"},{"count":1,"reaction":"BRONCHOSPASM"},{"count":1,"reaction":"GRANULOMA"}],"_approvalHistory":[],"publicationCount":4820,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lipitor","Zocor","Crestor","Tricor"],"phase":"phase_3","status":"active","brandName":"Lipid-lowering therapy","genericName":"Lipid-lowering therapy","companyName":"Takeda","companyId":"takeda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipid-lowering therapy reduces blood cholesterol and triglyceride levels through various pharmacological mechanisms to prevent cardiovascular disease. Used for Hyperlipidemia / dyslipidemia, Cardiovascular disease prevention, Secondary prevention post-myocardial infarction or stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}